Middle East News Network: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Middle East News Network.

Press releases published on May 7, 2026

May 7, 2026

Ardelyx Presents Analysis Supporting Long-Term Safety of XPHOZAH at NKF’s Spring Clinical Meetings

Indeterminate GlobeNewswire

May 7, 2026

MediWound to Report First Quarter 2026 Financial Results

Indeterminate GlobeNewswire

May 7, 2026

Praxis Precision Medicines Provides Corporate Update and Reports First Quarter 2026 Financial Results

Indeterminate GlobeNewswire

May 7, 2026

ALX Oncology’s Evorpacept in Combination with Zanidatamab Generates Promising, Durable Response in Patients with Advanced HER2-Positive Breast Cancer and High CD47 Expression

Indeterminate GlobeNewswire

May 7, 2026

UroGen Pharma to Present at Upcoming Investor Conferences

Indeterminate GlobeNewswire

May 7, 2026

Aardvark Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Updates

Indeterminate GlobeNewswire

May 7, 2026

SERB Pharmaceuticals Announces ThyroSafe 130 mg Potassium Iodide Tablets are Now Commercially Available in the US

Indeterminate GlobeNewswire

May 7, 2026

Micropolis Robotics Expands Industrial Automation Footprint with USD $1.2 Million EMSTEEL Agreement

Indeterminate GlobeNewswire

May 7, 2026

Halper AI Beat 15,000 Applicants to Win the 2026 Global Recognition Award. Now It Is Expanding Into Healthcare

Indeterminate GlobeNewswire

May 7, 2026

One Bullion Reports Gravity-Finish Assay Results at Vumba Project, Including 30.8 g/t Au, and Receives EIA Approval for Maitengwe Project

Indeterminate GlobeNewswire

May 7, 2026

Al Tamimi and Company Participated in Construction Week Dispute Resolution on 6 May 2026

Indeterminate GlobeNewswire

May 7, 2026

Entrada Therapeutics Reports First Quarter 2026 Financial Results

Indeterminate GlobeNewswire

May 7, 2026

Gilat to Present at Upcoming Investor Conferences

Indeterminate GlobeNewswire

May 7, 2026

Invivyd to Host First Quarter 2026 Financial Results and Corporate Update Call on May 14, 2026

Indeterminate GlobeNewswire

May 7, 2026

Foghorn Therapeutics Provides First Quarter 2026 Financial and Corporate Update

Indeterminate GlobeNewswire

May 7, 2026

Neumora Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Update

Indeterminate GlobeNewswire

May 7, 2026

Ligand Reports First Quarter 2026 Financial Results

Indeterminate GlobeNewswire

May 7, 2026

Entrada Therapeutics Announces Positive Topline Results from Cohort 1 of Participants with Duchenne Muscular Dystrophy Treated with ENTR-601-44 in Phase 1/2 ELEVATE-44-201 Study

Indeterminate GlobeNewswire

May 7, 2026

Drill Program is Underway at VR’s New Boston Moly-Tungsten-Copper-Silver Porphyry Project in Nevada

Indeterminate GlobeNewswire

May 7, 2026

Rapport Therapeutics Reports First Quarter 2026 Financials and Provides Business Update

Indeterminate GlobeNewswire